» Authors » Arianna Calcinotto

Arianna Calcinotto

Explore the profile of Arianna Calcinotto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 2108
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmidt R, Harder Y, Rossi L, Canino P, Schiaffino S, Calcinotto A, et al.
Medicina (Kaunas) . 2024 Nov; 60(11). PMID: 39596952
The Albumin-to-Alkaline Phosphatase ratio (AAPR) is an easily applicable and cost-effective marker investigated as an outcome predictor in solid cancers. Preliminary evidence in breast cancer suggests that a low AAPR...
2.
Rys R, Calcinotto A
Trends Cell Biol . 2024 Oct; PMID: 39362804
Neutrophils have recently received increased attention in cancer because they contribute to all stages of cancer. Neutrophils are so far considered to have a short half-life. However, a growing body...
3.
Gasparri M, Albasini S, Truffi M, Favilla K, Tagliaferri B, Piccotti F, et al.
Ther Adv Med Oncol . 2023 Sep; 15:17588359231193732. PMID: 37720495
Background: Systemic inflammatory markers draw great interest as potential blood-based prognostic factors in several oncological settings. Objectives: The aim of this study is to evaluate whether neutrophil-to-lymphocyte ratio (NLR) and...
4.
Brina D, Ponzoni A, Troiani M, Cali B, Pasquini E, Attanasio G, et al.
Nat Cancer . 2023 Jul; 4(8):1102-1121. PMID: 37460872
Cancer is highly infiltrated by myeloid-derived suppressor cells (MDSCs). Currently available immunotherapies do not completely eradicate MDSCs. Through a genome-wide analysis of the translatome of prostate cancers driven by different...
5.
Bancaro N, Cali B, Troiani M, Elia A, Arzola R, Attanasio G, et al.
Cancer Cell . 2023 Mar; 41(3):602-619.e11. PMID: 36868226
Tumor cells promote the recruitment of immunosuppressive neutrophils, a subset of myeloid cells driving immune suppression, tumor proliferation, and treatment resistance. Physiologically, neutrophils are known to have a short half-life....
6.
Bolis M, Bossi D, Vallerga A, Ceserani V, Cavalli M, Impellizzieri D, et al.
Nat Commun . 2021 Dec; 12(1):7033. PMID: 34857732
Comprehensive genomic studies have delineated key driver mutations linked to disease progression for most cancers. However, corresponding transcriptional changes remain largely elusive because of the bias associated with cross-study analysis....
7.
Zorzi M, Guzzinati S, Avossa F, Fedeli U, Calcinotto A, Rugge M
Front Oncol . 2021 Oct; 11:730131. PMID: 34707988
Aim: In a consecutive series of cancer patients tested for SARS-CoV-2 infection, this retrospective population-based study investigates the risks of viral infection and death. Methods: Malignancies were distinguished as incident...
8.
Bonfiglio F, Bruscaggin A, Guidetti F, di Bergamo L, Faderl M, Spina V, et al.
Blood . 2021 Oct; 139(5):732-747. PMID: 34653238
Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity. The clinical course is variable, multiple genes are mutated with no unifying mechanism, and essential regulatory pathways and surrounding...
9.
Pernigoni N, Zagato E, Calcinotto A, Troiani M, Mestre R, Cali B, et al.
Science . 2021 Oct; 374(6564):216-224. PMID: 34618582
The microbiota comprises the microorganisms that live in close contact with the host, with mutual benefit for both counterparts. The contribution of the gut microbiota to the emergence of castration-resistant...
10.
Grioni M, Brevi A, Cattaneo E, Rovida A, Bordini J, Bertilaccio M, et al.
Blood Adv . 2021 Jul; 5(14):2817-2828. PMID: 34269799
Chronic lymphocytic leukemia (CLL) is caused by the progressive accumulation of mature CD5+ B cells in secondary lymphoid organs. In vitro data suggest that CD4+ T lymphocytes also sustain survival...